Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO 2024 | Decentralized clinical trials to improve patient access

Many patients are unable to access clinical trials despite being eligible. Grzegorz Nowakoski, MD, Mayo Clinic, Rochester, MN, discusses the notion of decentralized clinical trials, which may minimize the burden of travel for patients and therefore improve their access. This interview took place at the Twelfth Annual Meeting of the Society of Hematologic Oncology (SOHO 2024) congress in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Consulting: MorphoSys, Celgene/Bristol Myers Squibb, Roche, Genentech, Kyte Pharma, Ryvu Therapeutics, Selvita, Curis, Karyopharm Therapeutics, Bantham Pharmaceutical, Daiichi Sankyo, Zai Labolatory, Incyte, Kymera Therapeutics, TG Therapeutics, Blueprint Medicines